Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,624,587
-$309,151 QoQ
Shares Held
20,774
-1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#750
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. GILD ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,823 | $277,901 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,624,587 | 20,774 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,933,738 | 21,050 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,664,439 | 21,708 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,402,262 | 21,642 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,436,922 | 21,980 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $2,558,997 | 22,838 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,092,088 | 22,649 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,869,967 | 22,304 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,536,383 | 22,393 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,413,798 | 19,301 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,523,636 | 18,808 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,345,472 | 17,954 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,387,337 | 18,001 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,481,097 | 17,851 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,556,718 | 18,133 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,075,688 | 17,437 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $946,743 | 15,317 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $787,534 | 13,247 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $934,708 | 12,873 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $896,664 | 12,837 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $786,518 | 11,422 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $697,616 | 10,794 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $515,076 | 8,841 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $783,050 | 12,392 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $892,657 | 11,602 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $850,918 | 11,382 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||